Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,872.40
(
0.00%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.01
(
4.78%
)
Bitcoin
75,384.70
(
-0.67%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 269
Posts 18896
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: biopharm post# 328365

Saturday, 09/01/2018 7:07:34 PM

Saturday, September 01, 2018 7:07:34 PM

Post# of 347009
Cambrex or Thermo Fisher for CDMO business acquisition—each has M/A activity in background. I am mindful of Xencor.

Meantime, we should be looking for evidence of milestones/royalties that could stem from success in clinical trials in which MRK is collaborating with UTSW, Oncologie.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote